PMID- 28895583 OWN - NLM STAT- MEDLINE DCOM- 20190626 LR - 20231112 IS - 1572-0241 (Electronic) IS - 0002-9270 (Print) IS - 0002-9270 (Linking) VI - 113 IP - 1 DP - 2018 Jan TI - Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles. PG - 31-38 LID - 10.1038/ajg.2017.263 [doi] AB - OBJECTIVES: Up to 50% of patients with reflux symptoms do not manifest a satisfactory symptom response to proton pump inhibitor (PPI) therapy. Our primary aim in this study was to identify factors associated with symptom perception among PPI non-responder phenotypes. METHODS: This prospective observational cohort study was performed from September 2014 to January 2017 at a single academic medical center and included PPI non-responders who underwent 24-h impedance-pH monitoring and completed a questionnaire set measuring patient-reported symptom severity, quality of life (QOL), and psychosocial distress. Participants were separated into cohorts based on impedance-pH results: on PPI: -acid exposure time (AET)/-symptom-reflux association (SRA), +AET, and -AET/+SRA; off PPI: functional (-AET/-SRA), gastroesophageal reflux disease (GERD) (+AET), and reflux hypersensitivity (RHS) (-AET/+SRA). The primary outcome was abnormal GERD symptom severity defined by GerdQ>/=8. RESULTS: One hundred and ninety-two participants were included. Impedance-pH on PPI was performed on 125: 72 (58%) -AET/-SRA, 42 (34%) +AET, and 11 (9%) -AET/+SRA. Among the -AET/-SRA group, younger age, higher dysphagia scores, QOL impairment, and higher brief symptom index were associated with GerdQ>/=8. Among the +AET group, higher number of reflux-associated symptoms and lower distal contractile integral was associated with GerdQ>/=8. Impedance-pH off PPI was performed on 67 participants: 39 (58%) functional, 16 (24%) GERD, and 12 (18%) RHS. Among the functional group, higher QOL impairment and dysphagia scores were seen with GerdQ>/=8. CONCLUSIONS: Perceptions of reflux symptoms are associated with psychosocial distress, reduced QOL, and sensation of dysphagia among PPI non-responders with normal impedance-pH. Among PPI refractory GERD patients, patient-reported symptom severity is associated with physiological differences, as opposed to psychosocial factors. FAU - Yadlapati, Rena AU - Yadlapati R AD - Division of Gastroenterology & Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. FAU - Tye, Michael AU - Tye M AD - Division of Gastroenterology & Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. FAU - Keefer, Laurie AU - Keefer L AD - Mount Sinai School of Medicine, New York, New York, USA. FAU - Kahrilas, Peter J AU - Kahrilas PJ AD - Division of Gastroenterology & Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. FAU - Pandolfino, John E AU - Pandolfino JE AD - Division of Gastroenterology & Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. LA - eng GR - R01 DK092217/DK/NIDDK NIH HHS/United States GR - T32 DK101363/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Observational Study PT - Research Support, N.I.H., Extramural DEP - 20170912 PL - United States TA - Am J Gastroenterol JT - The American journal of gastroenterology JID - 0421030 RN - 0 (Proton Pump Inhibitors) SB - IM MH - Adult MH - Cohort Studies MH - Deglutition Disorders/etiology/pathology/physiopathology MH - Electric Impedance MH - Esophageal pH Monitoring MH - Female MH - Gastroesophageal Reflux/complications/*drug therapy/physiopathology/psychology MH - Humans MH - Male MH - Manometry MH - Middle Aged MH - Patient Reported Outcome Measures MH - Patient Satisfaction MH - Prospective Studies MH - Proton Pump Inhibitors/*therapeutic use MH - *Quality of Life MH - Severity of Illness Index MH - *Stress, Psychological MH - Treatment Failure MH - Young Adult PMC - PMC5772841 MID - NIHMS933503 COIS- Potential Conflict of Interest (Financial, Professional or Personal): None EDAT- 2017/09/13 06:00 MHDA- 2019/06/27 06:00 PMCR- 2019/01/01 CRDT- 2017/09/13 06:00 PHST- 2017/03/31 00:00 [received] PHST- 2017/07/18 00:00 [accepted] PHST- 2017/09/13 06:00 [pubmed] PHST- 2019/06/27 06:00 [medline] PHST- 2017/09/13 06:00 [entrez] PHST- 2019/01/01 00:00 [pmc-release] AID - 10.1038/ajg.2017.263 [doi] PST - ppublish SO - Am J Gastroenterol. 2018 Jan;113(1):31-38. doi: 10.1038/ajg.2017.263. Epub 2017 Sep 12.